Distribution & channels · Expert interview

Why the pharmacist recommends a different brand: priority lists, rebates and bonuses behind the counter in Vietnam's pharmacy chains

Format
Modelled interview
As of
October 2026
Market
Vietnam
Industry
Pharmaceutical retail
Length
≈ 30 min read
Long ChâuFPT RetailPharmacityAn KhangMobile World InvestmentLeapFrog InvestmentsMinistry of Health
Modelled interview. Built from KIRA's face-to-face interviews with pharmacy chain store managers, pharmacists and counter staff, with independent pharmacy owners and with drug makers' people in another large Asian market, set in today's Vietnamese market. How the trade works comes from what those people told our analysts; every figure comes from a public source, marked next to the answer.

Summary

  • At the counter, the pharmacist rather than the patient usually starts a brand switch, and a low fixed salary makes the monthly bonus and the reward per box the real motivation. 1
  • The deal is made with headquarters, not with the clerk: a priority list, a lower purchase price and rebates for the chain, which come back to stores as group targets and bonuses. 2 3
  • The buyer is a concentrated one: Long Châu ended 2025 with 2,417 pharmacies averaging about VND1.2 billion of revenue each per month, and holds about 16% of the pharmaceutical market excluding vaccines, while modern chains as a whole held about 5.7% in early 2025. 4 5 6
  • Chains under margin pressure have more reason to steer: An Khang lost $13.88 million in 2024, and analysts expect Long Châu to lift margins through non-pharmaceutical sales and possibly private label. 6
  • The rules changed in 2025: chains are a legal business type, rotation of the responsible pharmacist must be notified, online sale of prescription drugs is prohibited, and offering material benefits to influence prescribing is a prohibited act for company representatives. 7 8
  • Makers who want to be recommended win with conditional rebates tied to sell-out, trained counter staff and packaging patients recall, not with unconditional discounts. 9

Transcript

01The counter decides, and it is not the patient

KAKIRA Analyst

You run a store in a national pharmacy chain. A patient walks in asking for the brand the doctor named. What happens in the next minute?

EXExpert

Honestly, the patient rarely starts the switch. The person behind the counter does, and it is usually the pharmacist. 1 They say something like: same active ingredient, a lower price, shall I show you? The reason is pay. The fixed salary is modest, so the monthly bonus and the reward per box are what really move behaviour. I can't show you my own payslip, and chains differ, but that is how the trade works in pharmacy chains across Asia. 1

The patient also switches without any help when the other box looks better. If a rival product sits at eye level with a good display and ours is on the bottom shelf, people reach for the rival. 10 So a brand that complains about pharmacists should first look at its own shelf. 10

KAKIRA Analyst

Does the story change with the type of drug?

EXExpert

Yes, the pitch changes. For a chronic-disease drug, the staff talk about price and the same active ingredient. 11 For pain relief or lifestyle products, they talk about how well it works and about side effects. 11 What does not change is that the brand the patient asked for is only the starting point of the conversation. 12

KAKIRA Analyst

And the doctor's writing on the prescription does not settle it?

EXExpert

Not always. Where the doctor writes only the generic name, the box in the patient's memory matters a great deal, so distinctive packaging really helps a brand to be asked for by name. 13 I tell supplier representatives that the packaging they are proud of is a sales tool at my counter, not just a design award. 13

02Who gets the money: headquarters, not the clerk

KAKIRA Analyst

People assume the drug company pays the clerk to recommend its product. Is that what happens?

EXExpert

That is the first thing outsiders get wrong. The drug company deals with headquarters. The deal is a priority drug list: the chain gets a lower purchase price and rebates, and headquarters sets targets for the priority products across its stores as a group. 2 The rebate is paid to the chain's centre, not to the individual clerk, and it comes back to us through the bonus scheme. 3

So the clerk does not feel a bribe. She feels a target on the monthly sheet, and she knows which products help her reach it. That is why one distribution desk in the head office matters more than a hundred visits to stores. 12

KAKIRA Analyst

How big a desk are we talking about?

EXExpert

Big. Long Châu closed 2025 with 2,417 pharmacies and 223 vaccination centres, and an average pharmacy there makes about VND1.2 billion of revenue a month. 4 A supplier who wants a place on that chain's list is negotiating once for the whole network, not with each store manager. 2 For 2026 the plan reported is about 340 more stores and a total of 2,737 pharmacies, so the desk will only get bigger. 14

KAKIRA Analyst

Is Long Châu the whole chain market, then?

EXExpert

No, and the numbers shift depending on who counts. One analyst estimate puts Long Châu at about 16% of Vietnam's pharmaceutical market excluding vaccines, in a market of about VND213.6 trillion. 5 An earlier report put all modern chains together at about 5.7% and private-run pharmacies at about 85% of the market, with more than 60,000 of them. 6 Both can be right, depending on the year and the definition. I would not build a plan on one number. 5 6

03Priority lists, local entrants and the supplier's side

KAKIRA Analyst

What does being on the priority list change for a product in your store?

EXExpert

It changes what the screen asks of me. A listed product gives the chain a better purchase price and rebate, so headquarters wants it to move, and my target includes it. 2 I do not see the contract itself, only the list and the numbers beside it, and I wouldn't claim more than that. 3

A product that is not on the list can still sell, but it has to earn its place on the shelf through patients asking for it or through a doctor's recommendation. 10 15

KAKIRA Analyst

How do local makers get onto those lists against the international brands?

EXExpert

Two routes I know from pharmacy chains elsewhere in Asia, and I see echoes of both in Vietnam. One is the top-priority deal for one year with a major chain, which the maker simply keeps renewing. 16 The other is to skip the rebate and give the pharmacy a much higher margin, and at the same time build doctors' recommendations in hospitals so patients ask for it. 15

KAKIRA Analyst

What about the rules? Is a rebate to a chain allowed?

EXExpert

I am a store manager, not a lawyer, so take this as how I read it. The rule I can point to concerns company representatives talking to doctors. Circular 31/2025/TT-BYT, effective from 1 July 2025, says offering material benefits to influence prescribing is a prohibited act. 8 That reads to me as being about prescribers. It says nothing I can find about a chain's purchase price. 8

What I can say is that the same circular makes chains something the Ministry tracks: the chain must give notice at least 7 working days before adding or removing a drugstore or moving the pharmacist in charge between stores. 8 So headquarters now has paperwork for every change in the network. 8

04Stock, margin and the pressure on chains

KAKIRA Analyst

You mentioned a buying method that changes what you push. Which one?

EXExpert

Outright purchase. If the chain has bought a lot of something and cannot send it back, the staff are encouraged to push that stock first, ahead of the brands they would otherwise recommend. 17 A good manager sees this coming, because the overstock sits in the warehouse list. A new brand salesman usually cannot see it at all. 17

KAKIRA Analyst

Does a chain's financial position matter to you at the counter?

EXExpert

In my reading, yes. A chain that is losing money cannot afford to leave margin on the shelf. An Khang lost $13.88 million in 2024, after $13.72 million in 2023 and $12.24 million in 2022. 6 It had 326 stores at the end of 2024, and 382 at the end of 2025, and its management expects 2026 to be the first profitable year. 6 5 I do not know how that pressure is turned into targets inside any particular chain. I only know that a chain in that position looks at the margin of every box. 12

The other chains are in different positions. Pharmacity says it returned to profit in Q4 2025, after cutting from more than 1,100 stores in Sep 2022 to fewer than 900 at the end of 2024, and it now has 1,118. 5 A chain that has survived a shrink is careful about what sits on the shelf. 12

KAKIRA Analyst

Where do analysts think the chains will find margin?

EXExpert

One broker expects Long Châu's margins to improve through higher non-pharmaceutical sales, and sees high-margin private-label products as a possible future move. 6 That is an analyst view, not something I have seen announced in my store. But if it happens, the counter will have a new thing to recommend: the chain's own box. 6

The discount chains in other Asian markets I know did the same earlier: sell a famous foreign brand near or below cost to bring people in, then steer them to a higher-margin local equivalent. 18 That is the pattern I would watch for here. 18

05What the law now says about chains and prescriptions

KAKIRA Analyst

The Pharmacy Law changed in 2025. What did that change for a chain store?

EXExpert

A chain is now its own legal type of business. The organising establishment needs at least 2 affiliated pharmacies with the business certificate and a uniform quality system, and members may rotate drugs and the pharmacist in charge among stores. 7 The law took effect on 1 July 2025. 7 For me, the practical result is that when a pharmacist moves between stores the head office has a formal process, with the notice period I mentioned. 8

KAKIRA Analyst

And prescription drugs?

EXExpert

Prescription drugs are described as over 82% of the drugs circulating on the market, so the rule matters for everyone, not just for hospital pharmacies. 7 The law prohibits online retail of prescription drugs, with a narrow exception for medical isolation after a declared Group A infectious disease epidemic. 7 So the counter remains the place where a prescription drug is sold, and the pharmacist remains the person who decides what goes in the bag. 7 1

KAKIRA Analyst

What about the electronic prescription? Has it changed the counter yet?

EXExpert

In principle it should, because the system is meant to let a pharmacy verify that a prescription is genuine and not expired. 19 Public hospitals have been sending e-prescriptions to the national system since late 2022, and in the report I read private facilities were in the final stages of connection. 19 I will not pretend I see it working everywhere. In my store it depends on whether the doctor's clinic is connected. 19

If e-prescriptions become the normal way, the room for a pharmacist to swap what the doctor wrote will narrow, and that is good for the original brand. But the patient who comes without any prescription, for pain relief or a supplement, will still be talking to the counter. 19 11

06What a drug maker can do about it

KAKIRA Analyst

If you were the brand, how would you answer the counter?

EXExpert

I would not try to out-discount the chain. The approaches that work in pharmacy chains elsewhere in Asia are point-of-sale materials, distinctive packaging, training in how to pitch for the counter staff, patient talks, and rebates that depend on sell-out targets rather than being paid unconditionally. 9 The conditional rebate is the one I would insist on, because it ties your money to what really leaves the store. 9

The poster is the small thing I would not forget. In the market I learned this from, a brand supplied window posters and sales of the product in that store rose sharply. 20 Your representative in Vietnam should therefore ask the store manager what display they have, not just whether the order is in. 10

KAKIRA Analyst

You mentioned training. Does it really change anything?

EXExpert

When the pharmacist can explain in two sentences why your product suits this patient, it competes with the cheaper one. If they cannot, they say same ingredient and cheaper. 11 I would rather my staff were trained by a supplier who shows them the difference than guess. But every supplier says that, and I have seen the training slides, they are not equal. 9

07Advice to a newcomer, and what worries me

KAKIRA Analyst

A Japanese or Korean maker is coming in. Where should it start?

EXExpert

Start at headquarters, not at the stores. Priority lists, rebates and targets cascade from there, and the staff incentive and the head-office deal decide brand choice more than the patient's preference for most chronic drugs. 12 Then go to the stores and make sure the shelf and the people behind the counter match what you agreed upstairs. 10

And expect a short first deal. A local maker's route is often a one-year priority agreement that is renewed, and a newcomer should see the first year as a test, not a settlement. 16 Scale decides who is in front of you: the largest chain alone has 2,678 stores as of early June 2026, about 2.4 times Pharmacity's network. 5

KAKIRA Analyst

What worries you most?

EXExpert

That the buyer gets bigger while the brand gets weaker. The plan for 2026 adds about 340 Long Châu stores to reach 2,737 pharmacies, and the chain's own margin story points to non-pharmaceutical lines and perhaps its own boxes. 14 6 A maker whose product depends on one list is exposed to the day the list changes. 12

KAKIRA Analyst

And what would change your mind about how much the counter matters?

EXExpert

If electronic prescriptions reach most private clinics and the pharmacy can see exactly what was written, the counter's room to swap will be much smaller than I describe. 19 I would also change my mind if I saw a supplier win shelf share with no deal at all and no doctor behind it, because everything I know says the deal or the doctor comes first. 15

Sources and basis

  1. 1
    Counter staff, usually pharmacists, drive most brand switches; their low fixed salary makes the monthly bonus and the reward per box the real motivation
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  2. 2
    Drug makers sign priority-drug-list deals with chain headquarters: a lower purchase price plus rebates, and headquarters sets store targets for the priority products as a group
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  3. 3
    Rebates are paid to headquarters, not to individual clerks, and flow back to stores through the bonus schemes
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  4. 4
    Long Châu (FPT Retail) in 2025: revenue of VND34,501 billion, up 36% and 68% of FPT Retail's consolidated revenue of VND51,083 billion; 474 new pharmacies and 97 new vaccination centres opened; 2,417 pharmacies and 223 vaccination centres at year-end (2,640 Long Châu outlets in total); average revenue of about VND1.2 billion per pharmacy per month
    Public source · The Investor, 30 Jan 2026 · link
  5. 5
    Pharmacity has 1,118 stores, about 300 more than at the end of 2024, when it had fewer than 900 (it had more than 1,100 in Sep 2022), and says it returned to profit in Q4 2025; Long Châu had 2,678 stores in early June 2026, about 2.4 times Pharmacity's network, and holds about 16% of Vietnam's pharmaceutical market excluding vaccines (VIX Securities estimate; market of about VND213.6 trillion); An Khang (Mobile World Investment) had 500 stores in 2022, 382 at end-2025 and 416 by end-May 2026, and management expects 2026 to be its first profitable year
    Public source · The Investor, 14 Jul 2026 · link
  6. 6
    Vietnam has more than 60,000 private-run pharmacies, about 85% of the market, while modern pharmacy chains hold about 5.7%; An Khang lost $12.24 million in 2022, $13.72 million in 2023 and $13.88 million in 2024 and had 326 stores at the end of 2024; BVSC expects Long Châu's margins to improve through higher non-pharmaceutical sales and sees high-margin private-label products as a possible future move (analyst view as reported)
    Public source · Vietnam Investment Review, 27 Mar 2025, reported by Vietstock · link
  7. 7
    The 2024 Law amending and supplementing a number of articles of the Law on Pharmacy was passed on 21 November 2024 and takes effect on 1 July 2025; a pharmacy chain becomes a separate type of business, whose organising establishment must have at least 2 affiliated pharmacies with a business eligibility certificate and a uniform quality management system, and chain members may rotate drugs and the person responsible for professional activities among pharmacies; online retail of prescription drugs is prohibited (exception: medical isolation after a declared Group A infectious disease epidemic); prescription drugs are described as over 82% of drugs circulating on the market
    Public source · Viet An Law, note on the revised Pharmacy Law 2024, accessed Oct 2026 · link
  8. 8
    Ministry of Health Circular 31/2025/TT-BYT, issued 1 July 2025 and effective 1 July 2025, ends the effect of Circular 07/2018/TT-BYT from 1 July 2025 and details the Law on Pharmacy and Decree 163/2025/ND-CP; the chain-organising establishment must notify the provincial health agency of certificate holders within 15 days of the certificate of eligibility being issued or the holders changing, and give notice at least 7 working days before adding or removing a drugstore or rotating the person in charge among chain drugstores; drug information representatives may introduce drugs to practitioners only with their consent, and offering material benefits to influence prescribing is a prohibited act
    Public source · Ministry of Health, English text hosted by LuatVietnam, 1 Jul 2025 · link
  9. 9
    Multinational makers counter switching with point-of-sale materials, distinctive packaging, sales-pitch training for counter staff, patient talks, gifts, and rebates that are conditional on sell-out targets rather than unconditional
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  10. 10
    Patients also switch on their own when they see a rival product better displayed or promoted in the store
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  11. 11
    For chronic-disease drugs staff pitch price and the same active ingredient; for pain relief and lifestyle drugs they pitch efficacy and side effects
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  12. 12
    Headquarters is the commercial control point in a chain: priority lists, rebates and targets cascade from there to the stores, and at the counter the staff incentive and the headquarters deal decide brand choice more than patient preference for most chronic drugs
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  13. 13
    When prescriptions are written by generic name, distinctive brand packaging becomes important for patient recall
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  14. 14
    FPT Retail's 2026 plan, a board resolution that still needs shareholder approval, reported with BIDV Securities estimates: net addition of about 340 Long Châu stores, bringing the total to 2,737 pharmacies; stores open more than 12 months average over VND1.2 billion in monthly revenue
    Public source · The Investor, 9 Feb 2026 · link
  15. 15
    Another local brand won without rebates by offering pharmacies much higher margins and building doctors' recommendations in hospitals
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  16. 16
    A local maker can enter by signing one-year top-priority deals with the major chains and renewing them each year
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  17. 17
    When a chain buys stock outright and cannot return it, staff push the overstock ahead of the brands they had planned to recommend
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  18. 18
    Discount chains sell well-known foreign brands near or below cost to draw traffic, then steer patients to higher-margin local equivalents
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market
  19. 19
    The Ministry of Health's national e-prescription system is meant to let pharmacies verify a prescription's authenticity and expiry status; public healthcare facilities have been sending e-prescriptions to it since late 2022, private facilities were in the final stages of connection, and the Viet Nam Medical Informatics Association is working with 48 departments of health nationwide to guide facilities and pharmacies
    Public source · Viet Nam News, 27 Mar 2024 · link
  20. 20
    After a brand supplied window posters, sales of that product in the store rose sharply
    KIRA field interviews · KIRA field interviews, pharmacy chains in another large Asian market

Key points

Practitioner views from KIRA Experts transcripts: modelled interviews built on KIRA's field interviews. How we work: Methodology.

More on Pharmacy chains in Vietnam